Multiple sclerosis (MS) is a chronic, progressive, and disabling inflammatory neurologic condition that causes more disability than any other nontraumatic neurologic condition. Early diagnosis, treatment, and monitoring of disease progression is fundamental to optimizing management of patients with MS. Join Edward Fox, MD, PhD, and Matthew Schindler, MD, PhD, in an interactive case-based roadmap for improved outcomes in patients with MS. In addition to addressing diagnostic challenges, Drs. Fox and Schindler share their insights into integrating advances in the pharmacologic treatment of patients with MS, focusing on the safety and efficacy of targeted therapies.
1 AMA PRA Category 1 CreditTM
1 ANCC Contact Hour
0.25 Pharmacology Hours
This activity was developed for neurologists, physician assistants, nurse practitioners, and allied healthcare professionals who diagnose and manage patients with multiple sclerosis (MS).
This activity is supported by educational grants from Genentech, a member of the Roche Group, and Novartis.
Edward J. Fox, MD, PhD
Director, MS Clinic of Central Texas
Central Texas Neurology Consultants, PA
Clinical Associate Professor, University of Texas Dell Medical School
Round Rock, Texas
Matthew K. Schindler, MD, PhD
Assistant Professor of Neurology, MS Division
Perelman School of Medicine
University of Pennsylvania